143 related articles for article (PubMed ID: 2601845)
1. Localization of striatal dopamine receptor function by central injection of an irreversible receptor antagonist.
Cameron DL; Crocker AD
Neuroscience; 1989; 32(3):769-78. PubMed ID: 2601845
[TBL] [Abstract][Full Text] [Related]
2. Effects of inactivation of D1 dopamine receptors on stereotypic and thermic responses to quinpirole (LY 171555).
Double KL; Crocker AD
Neurosci Lett; 1990 Jul; 115(1):81-5. PubMed ID: 1977110
[TBL] [Abstract][Full Text] [Related]
3. Alkylation of striatal dopamine receptors abolishes stereotyped behavior but has no effect on dopamine stimulated adenylate cyclase activity.
Cameron DL; Crocker AD
Neurosci Lett; 1988 Jul; 90(1-2):165-71. PubMed ID: 3045699
[TBL] [Abstract][Full Text] [Related]
4. Stereotypies elicited by injection of N-propylnorapomorphine into striatal subregions and nucleus accumbens.
Bordi F; Carr KD; Meller E
Brain Res; 1989 Jun; 489(2):205-15. PubMed ID: 2568153
[TBL] [Abstract][Full Text] [Related]
5. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.
Delfs JM; Kelley AE
Neuroscience; 1990; 39(1):59-67. PubMed ID: 1982467
[TBL] [Abstract][Full Text] [Related]
6. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
Wachtel SR; Hu XT; Galloway MP; White FJ
Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
[TBL] [Abstract][Full Text] [Related]
7. Localization of dopamine receptor subtypes occupied by intra-accumbens antagonists that reverse cocaine-induced locomotion.
Neisewander JL; O'Dell LE; Redmond JC
Brain Res; 1995 Feb; 671(2):201-12. PubMed ID: 7743209
[TBL] [Abstract][Full Text] [Related]
8. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
Giorgi O; Biggio G
Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
[TBL] [Abstract][Full Text] [Related]
9. Behavioral recovery after irreversible inactivation of D-1 and D-2 dopamine receptors.
Meller E; Bordi F; Bohmaker K
Life Sci; 1989; 44(15):1019-26. PubMed ID: 2564615
[TBL] [Abstract][Full Text] [Related]
10. Chronic eticlopride and dopamine denervation induce equal nonadditive increases in striatal D2 receptor density: autoradiographic evidence against the dual mechanism hypothesis.
LaHoste GJ; Marshall JF
Neuroscience; 1991; 41(2-3):473-81. PubMed ID: 1678501
[TBL] [Abstract][Full Text] [Related]
11. Expression of stereotyped behaviour requires stimulation of nigral D1 dopamine receptors.
Lee CY; Double KL; Crocker AD
Brain Res; 1995 May; 681(1-2):205-8. PubMed ID: 7552282
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum.
Cenci MA; Kalén P; Mandel RJ; Wictorin K; Björklund A
Neuroscience; 1992; 46(4):943-57. PubMed ID: 1347413
[TBL] [Abstract][Full Text] [Related]
13. Dopamine receptors in the substantia nigra are involved in the regulation of muscle tone.
Double KL; Crocker AD
Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1669-73. PubMed ID: 7878037
[TBL] [Abstract][Full Text] [Related]
14. Effect of raclopride on dopamine D2 receptor mRNA expression in rat brain.
Kopp J; Lindefors N; Brené S; Hall H; Persson H; Sedvall G
Neuroscience; 1992; 47(4):771-9. PubMed ID: 1533704
[TBL] [Abstract][Full Text] [Related]
15. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
16. Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents.
Protais P; Chagraoui A; Arbaoui J; Mocaër E
Eur J Pharmacol; 1994 Dec; 271(1):167-77. PubMed ID: 7698199
[TBL] [Abstract][Full Text] [Related]
17. Behavioral and neurochemical modifications induced by apomorphine treatment.
Piervincenzo P; Luciana G; Laura C; Giuseppe A
Neurosci Lett; 1989 May; 100(1-3):265-70. PubMed ID: 2761776
[TBL] [Abstract][Full Text] [Related]
18. Receptor reserve at striatal dopamine receptors modulating the release of [3H]dopamine.
Yokoo H; Goldstein M; Meller E
Eur J Pharmacol; 1988 Oct; 155(3):323-7. PubMed ID: 3234490
[TBL] [Abstract][Full Text] [Related]
19. Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
Hamblin MW; Creese I
Life Sci; 1983 May; 32(19):2247-55. PubMed ID: 6133202
[TBL] [Abstract][Full Text] [Related]
20. Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy.
Ossowska K; Karcz M; Wardas J; Wolfarth S
Eur J Pharmacol; 1990 Jul; 182(2):327-34. PubMed ID: 1975782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
